| Factor Information | |
|---|---|
| Data ID | 69 |
| Factor | outcome of ischemic placental disease |
| Description | Women with ACHD had significantly lower odds of ischemic placental disease compared with the general obstetric population (ie, anomalies of venous return, anomalies of the atria and interatrial communications, and anomalies of the atrioventricular junctions and valves |
| Biomarker | NA |
| Classification | A3 (clinical factor - disease & symptom) |
| Association | |
|---|---|
| Application | prognosis |
| Objective | To assess the association of ACHD and its subtypes with pregnancy outcomes of ischemic placental disease |
| p Value | <0.05 |
| OR | 0.1 |
| Conclusion | Women with ACHD had significantly lower odds of ischemic placental disease compared with the general obstetric population (ie, anomalies of venous return, anomalies of the atria and interatrial communications, and anomalies of the atrioventricular junctions and valves |
| Risk Factor | protective factor |
| CHD Type | |
|---|---|
| ID | 406 |
| CHD Type | non-isolated CHD |
| CHD Subtype | Anomalies of atrioventricular junctions and valves |
| Reference | |
|---|---|
| PMID | 31074818 |
| Year | 2019 |
| Title | Association of Adult Congenital Heart Disease With Pregnancy, Maternal, and Neonatal Outcomes. |
| Sample | ||
|---|---|---|
| Population | Adults (women) | |
| Source | Discharge Abstract Database | |
| Region | all hospitalizations in Canada (except Quebec), Canada | |
| Method | cross-sectional study | |
| Race | North America | |
| Disease History | N/A | |
| Treatment History | N/A | |
| Group | women with Anomalies of atrioventricular junctions and valves(Treatment) | women without ACHD(Control) |
| Number | 196 (total:1440) | 384811 (total:2682451) |
| Age | 29.4±5.7 (M±SD) | 29.8±5.6 (M±SD) |
| Gender (Male: Female) | 0:196 | 0:384811 |
| Marker Level | 0.136 | 0.143 |
